Advancing Breast Cancer Screening with AI Technology

In a review published by the European Journal of Radiology, researchers explored the potential of Artificial Intelligence (AI) to revolutionize breast cancer screening through advancements in digital mammography (DM) and digital breast tomosynthesis (DBT).

AI in breast cancerBreast Cancer ScreeningDigital Mammography
PublishedOct 09, 2024 Reading time2 min
Advancing Breast Cancer Screening with AI Technology

In a review published by the European Journal of Radiology, researchers explored the potential of Artificial Intelligence (AI) to revolutionize breast cancer screening through advancements in digital mammography (DM) and digital breast tomosynthesis (DBT).

Key Findings and Challenges

Deep Learning (DL)-based AI systems have shown considerable promise, significantly enhancing detection accuracy and reducing the workload for radiologists. With improved capabilities to identify subtle abnormalities, AI has demonstrated an ability to both reduce false positives and negatives, providing more consistent results and potentially surpassing traditional computer-aided detection (CAD) systems.

However, while AI systems offer substantial benefits, this review highlights several challenges. Issues such as data quality, potential biases in training data, and regulatory complexities are significant barriers to the broader clinical adoption of AI in breast imaging. Moreover, the article emphasizes the importance of standardized guidelines and reliable practices, such as the FUTURE-AI framework, to build clinical trust and ensure fairness, robustness, and explainability in AI applications.

The Future of AI in Breast Cancer Screening

With standardized guidelines, increased collaboration among researchers, and adherence to trustworthy AI practices, AI technology could significantly advance the accuracy, fairness, and reliability of breast cancer screenings worldwide. Ongoing efforts, like federated learning, aim to enhance the quality and generalizability of AI models, ensuring robust clinical performance across diverse populations.

The integration of AI in breast cancer screening is poised to be a major leap forward. However, continuous research, clinical trials, and regulatory guidance will be essential to fully unlock AI’s potential in healthcare. This review highlights the collaborative efforts needed to bring these transformative technologies into routine practice, ultimately improving patient outcomes and empowering healthcare providers.

Read the full article for more details

Reference

Díaz, O., Rodríguez-Ruíz, A., & Sechopoulos, I. (2024). Artificial intelligence for breast cancer detection: Technology, challenges, and prospects. European Journal of Radiology, 175, 111457. https://doi.org/10.1016/j.ejrad.2024.111457

Monthly digest

Liked this? Get the next one in your inbox.

One email a month with our best writing, product launches and the conferences where you can meet the team. No spam, no share.

By subscribing you agree to receive PAICON's monthly digest. Unsubscribe anytime.